Results 91 to 98 of about 5,177 (98)

A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation

Analytical Biochemistry, 2004
Paul J. Hergenrother, Karson S Putt
exaly  

Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity

Experimental Cell Research, 2007
Ralph Meyer, Mirella L Meyer-Ficca, Elaine L Jacobson   +2 more
exaly  

PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair

EMBO Journal
Hendrik Johannes Kuiken, Jos Jonkers, Sven Rottenberg   +2 more
exaly  

People also looked at

Frontiers in Pharmacology, 2019
Zhuoying Zeng, Linqing Yang
exaly  

Prospects for PARG inhibitors in cancer therapy Open Access

Journal of Molecular Cell Biology
Ji Jing, Zu Ye, Yangchan Hu
exaly  

PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy

Journal of Hepatology
Hui Li, Ye Qinghai, Peiyi Xie
exaly  

Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation.

NAR Cancer
Anthony Tighe, Beth Barnes, Richard Unwin   +2 more
exaly  

Efficient synthesis of imidazo[1,5-]pyridine sulfonamido derivative as a PARG inhibitor

Tetrahedron
exaly